CentraLabS have provided specialist safety testing for phase I studies around the globe for over 20 years. We understand the specific requirements for this important segment of clinical research:

• Rapid set-up times (<5 days for standard studies)
• Flexible reporting formats (integrating PK with safety reports)
• STAT turnaround of all phase I safety samples
• Dedicated Phase I project management
• Wide range of in-house testing capabilities

We have extensive experience in validation, method development and clinical analysis and a logistics infrastructure geared to support shipment of time-sensitive / labile samples, as well as to provide rapid turnaround of safety data.

We consistently deliver because your investigator sites, and the people they enrol, demand it.